HIGHLIGHTS
SUMMARY
Optimal conduct and reporting of preclinical laboratory experiments are critical to support reproducible research. To encourage both rigorous conduct and transparent reporting, the National Institutes of Health (NIH) assembled international stakeholders to reach a consensus on essential reporting items in preclinical animal research. In Vivo Experiments (ARRIVE) guideline and the recent 2020 ARRIVE 2.0 guideline, such domains represent important considerations for conduct; "guidelines and associated resources are useful throughout the course of a study" including "during study planning" and "during the conduct of a study". Throughout this study, the authors refer to "using . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.